During the stage of PMI, a series of immune-related genes expression were increased in the absence of inflammatory insult, such as interleukins (ILs), CC-chemokine ligand 2 (CCL2) and MMPs, which are also related to breast cancer development [13]. The gene discussed is CCL2; the disease is breast carcinoma.